Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH Pretreatment for Radioiodine Therapy in Nodular Goiter
NCT00145366Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Apr 2002
- Modality
- Biologic, rProtein (Recombinant Protein), Hormone
- Countries
- 1
01
Overview
A Phase 2 trial of thyrotropin alfa in nodular goiter, Graves' disease, sponsored by University Hospital Odense. Started Apr 2002; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
nodular goiterGraves' disease
Beyond the preview
Go deeper on NCT00145366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145366.